ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 172 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $752,000 | -14.4% | 60,428 | -5.8% | 0.02% | -9.5% |
| Q3 2016 | $878,000 | -20.8% | 64,167 | -57.2% | 0.02% | -8.7% |
| Q2 2016 | $1,109,000 | +435.7% | 150,016 | +362.3% | 0.02% | +283.3% |
| Q1 2016 | $207,000 | -51.9% | 32,451 | -52.8% | 0.01% | -14.3% |
| Q4 2015 | $430,000 | -36.3% | 68,753 | -40.5% | 0.01% | -36.4% |
| Q3 2015 | $675,000 | -33.0% | 115,643 | -5.0% | 0.01% | -38.9% |
| Q2 2015 | $1,007,000 | +38.7% | 121,761 | +38.1% | 0.02% | +20.0% |
| Q1 2015 | $726,000 | +109.2% | 88,150 | +37.1% | 0.02% | +114.3% |
| Q3 2014 | $347,000 | -39.2% | 64,282 | -28.4% | 0.01% | -22.2% |
| Q2 2014 | $571,000 | +175.8% | 89,733 | +250.0% | 0.01% | +200.0% |
| Q1 2014 | $207,000 | -76.2% | 25,640 | -45.7% | 0.00% | -72.7% |
| Q3 2013 | $868,000 | – | 47,204 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $80,313,000 | 15.61% |
| Opaleye Management Inc. | 1,310,000 | $8,188,000 | 3.42% |
| Camber Capital Management LP | 5,405,235 | $33,783,000 | 2.18% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 471,516 | $2,947,000 | 1.22% |
| HighVista Strategies LLC | 807,100 | $5,044,000 | 0.94% |
| JS Capital Management LLC | 630,000 | $3,938,000 | 0.94% |
| 1492 Capital Management LLC | 202,500 | $1,266,000 | 0.92% |
| Palo Alto Investors LP | 2,257,217 | $14,108,000 | 0.78% |
| Geduld E E | 185,100 | $1,157,000 | 0.72% |
| Elk Creek Partners, LLC | 1,592,527 | $9,953,000 | 0.71% |